Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to current ...

Carla Tardi is a technical editor and digital content producer with 25+ years of experience at top-tier investment banks and money-management firms. David Kindness is a Certified Public Accountant ...

8 old programming languages developers won’t quit Newer languages might soak up all the glory, but these die-hard languages have their place. Here are eight languages developers still use daily, and ...